238. Antimicrobial Activity of Dalbavancin against Gram-Positive Bacteria Isolated from Patients with Bone and Joint Infections from the United States (US) and Europe (2016-2020): Results from the International Dalbavancin Evaluation of Activity (IDEA) Program

BACKGROUND: Bone and joint infections (BJI) comprise a series of disorders, including septic arthritis, osteomyelitis, and prosthetic joint infections. Dalbavancin (DALBA) is a lipoglycopeptide with a very long half-life that allows the treatment of serious infections with once weekly or biweekly ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Sader, Helio S, Duncan, Leonard R, Castanheira, Mariana, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644298/
http://dx.doi.org/10.1093/ofid/ofab466.440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644298/
http://dx.doi.org/10.1093/ofid/ofab466.440

Ejemplares similares